Chapter 9 292 34. Vrooman CB, J.; Iedema, J.; van der Torre. Contemporary inequality: The post-industrial class structure based on four types of capita (English). Disparities in the Netherlands 2023. The Hague: The Netherlands Institute for Social Research, 2023. 35. de Klerk MO, M.; Plaisier, I.; Schaper, J.; Wagemans, F. Een jaar met corona: Ontwikkelingen in de maatschappelijke gevolgen van corona. The Hague: Sociaal en Cultureel Planbureau, 2021 March 2021. 36. Dolby T, Finning K, Baker A, et al. Monitoring sociodemographic inequality in COVID-19 vaccination uptake in England: a national linked data study. Journal of Epidemiology and Community Health 2022; 76(7): 646. 37. Nafilyan V, Dolby T, Razieh C, et al. Sociodemographic inequality in COVID-19 vaccination coverage among elderly adults in England: a national linked data study. BMJ Open 2021; 11(7): e053402. 38. Painter EM UE, Patel A, et al. Demographic Characteristics of Persons Vaccinated During the First Month of the COVID-19 Vaccination Program — United States, December 14, 2020–January 14, 2021. MMWR Morb Mortal Wkly Rep 2021 2021; 70: 174–7. 39. Rydland HT, Friedman J, Stringhini S, Link BG, Eikemo TA. The radically unequal distribution of Covid-19 vaccinations: a predictable yet avoidable symptom of the fundamental causes of inequality. Humanities and Social Sciences Communications 2022; 9(1): 61. 40. WHO WHO. COVAX: Working for global equitable access to COVID-19 vaccines. Available at: https://www.who.int/initiatives/act-accelerator/covax. Accessed Jan 11. 41. Gavi TVA. Available at: www.gavi.org. 42. CEPI. Preparing for future pandemics. Available at: www.cepi.net. 43. Edouard Mathieu HR, Lucas Rodés-Guirao, Cameron Appel, Charlie Giattino, Joe Hasell, Bobbie Macdonald, Saloni Dattani, Diana Beltekian, Esteban Ortiz-Ospina and Max Roser. Coronavirus Pandemic (COVID-19). Coronavirus (COVID-19) Vaccinations. OurWorldInData.org, 2020. 44. The Lancet Infectious D. COVID-19 vaccine equity and booster doses. (1474-4457 (Electronic)). 45. McIntyre PB, Aggarwal R, Jani I, et al. COVID-19 vaccine strategies must focus on severe disease and global equity. (1474-547X (Electronic)). 46. WHO. Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors. Geneva: World Health Organization, 2023 22 March 2023. Report No.: ISBN 978-92-4-006944-2. 47. The Lancet Public H. HIV 40: inequalities fuel pandemics. The Lancet Public Health 2021; 6(7): e434. 48. CDC. Fast Facts on Global Immunization. Available at: https://www.cdc.gov/globalhealth/ immunization/data/fast-facts.html. Accessed 29 May. 49. WHO WHO. Access to medicines: making market forces serve the poor, 2017. 50. (NICE) NIfHCE. COVID-19 rapid guideline: managing the long-term effects of COVID-19 NG188 Vol. 2021: NICE, 2021. 51. Elke W, Godelieve JdB, Tjalling L, et al. Selection of long COVID symptoms influences prevalence estimates in a prospective cohort. medRxiv 2022: 2022.11.09.22282120. 52. Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review The Journal of Infectious Diseases 2022; 226(9): 1593-607.
RkJQdWJsaXNoZXIy MTk4NDMw